VistaGen Therapeutics, Inc.

/VistaGen Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company committed to developing new generation therapies for anxiety, depression and certain additional central nervous system (CNS) disorders for which we believe current treatment options are inadequate, resulting in high unmet need in large and growing markets worldwide.

Symbol

Last Closing Price
$0.87

Shares
12,000,000

Anticipated Date
August 3, 2020

Underwriters

This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange